Inogen Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Inogen, Inc. (NASDAQ: INGN) has announced its participation in the 39th Annual J.P. Morgan Healthcare Conference. The Company’s President and CEO, Scott Wilkinson, along with CFO, Alison Bauerlein, will present on January 12, 2021, at 5:20 p.m. EST. Investors can access a live audio webcast through Inogen's Investor Relations page, with a replay available for 90 days post-event. Inogen specializes in developing and marketing portable oxygen concentrators for patients with chronic respiratory conditions, emphasizing its commitment to innovation in homecare respiratory products.

Positive

• Participation in a prominent healthcare conference may enhance company visibility and investor interest.
• Continued focus on innovative respiratory products aligns with market demand for homecare solutions.

Negative

• None.

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 39^th Annual J.P. Morgan Healthcare Conference.

Inogen’s President and CEO, Scott Wilkinson, and CFO, Alison Bauerlein, are scheduled to present on Tuesday, January 12^th, 2021 at 5:20 p.m. EST. Interested parties can access the live audio webcast from the News / Events section of the Investor Relations page on the Inogen website at www.inogen.com. A webcast replay will be available approximately one hour after the conclusion of the live presentation and will remain available for 90 days.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201218005009/en/

FAQ

When is Inogen's presentation at the J.P. Morgan Healthcare Conference?

Inogen's presentation is scheduled for January 12, 2021, at 5:20 p.m. EST.

Where can I access the live audio webcast of Inogen's presentation?

The live audio webcast can be accessed on Inogen's Investor Relations page on their website.

What is Inogen's main focus in the medical technology sector?

Inogen primarily develops and markets portable oxygen concentrators for chronic respiratory conditions.